Compare PCRX & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | CCNE |
|---|---|---|
| Founded | 2006 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 736.3M |
| IPO Year | 2011 | N/A |
| Metric | PCRX | CCNE |
|---|---|---|
| Price | $26.06 | $26.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | ★ $32.86 | $29.00 |
| AVG Volume (30 Days) | ★ 869.1K | 137.2K |
| Earning Date | 11-06-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.47 | ★ 1.91 |
| Revenue | ★ $716,791,000.00 | $227,923,000.00 |
| Revenue This Year | $6.24 | $13.84 |
| Revenue Next Year | $9.53 | $27.68 |
| P/E Ratio | $55.29 | ★ $13.95 |
| Revenue Growth | 3.14 | ★ 5.27 |
| 52 Week Low | $18.17 | $19.32 |
| 52 Week High | $27.64 | $28.04 |
| Indicator | PCRX | CCNE |
|---|---|---|
| Relative Strength Index (RSI) | 58.98 | 46.26 |
| Support Level | $25.56 | $26.68 |
| Resistance Level | $26.70 | $27.15 |
| Average True Range (ATR) | 0.94 | 0.46 |
| MACD | -0.04 | -0.21 |
| Stochastic Oscillator | 59.77 | 4.34 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.